Benitec Biopharma Inc

NASDAQ:BNTC   3:46:11 PM EDT
3.02
-0.05 (-1.57%)
5:34:41 PM EDT: $3.02 0.00 (-0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Benitec Biopharma Inc Stock, NASDAQ:BNTC

3940 Trust Way, Hayward, California 94545
United States of America
Phone: +61.3.8692.7222
Number of Employees: 18

Description

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firms' proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on November 22, 2019 and is headquartered in Hayward, CA.